Brom Rector, Founder, and GP of Empath Ventures. Prior to founding Empath, Brom spent 7 years as a portfolio manager and quantitative researcher - most recently managing a global macro portfolio for Crabel Capital Management - a Los Angeles-based hedge fund with $8B AUM. After leaving Crabel in 2020, Brom started The Integration Conversation, a long-form video podcast that covers the psychedelics industry from an investing perspective. The research that went into this podcast and the connections it established laid the groundwork for what would become Empath Ventures. On this episode, Brom gives a breakdown on the breakdown of the Psychedelic industry and landscape. They discuss why Brom raised a fund to target psychedelics and how he's investing the money and why it's one of the largest opportunities in the world. Listen to hear Brom’s thoughts on what the next 10 years of psychedelics might look like and much more! Follow Chris on Twitter: www.Twitter.com/FortWorthChris  Follow Chris on LinkedIn: www.linkedin.com/in/chrispowersjr/  Subscribe to The Fort on YouTube: https://www.youtube.com/channel/UCuJ32shRt8Od3MxMY-keTSQ Follow The Fort on Instagram: www.Instagram.com/TheFortPodcast (01:56) - Brom’s Background and Career in Psychedelics Empath ventures (07:22) - Why have psychedelics been illegal and shunned from society? (11:28) - What’s Big Pharma’s role in this? (12:49) - What is the chemical reaction happening inside the body when one takes psychedelics? (14:38) - Are all psychedelics man-made or are there any occurring in nature? (16:03) - How far back do psychedelics go in human history? (17:20) - How big is this industry from an economic standpoint? Data on funding trends in psychedelics:  https://www.cbinsights.com/research/psychedelic-therapies-funding-startups/ (20:09) - How do we define what is legal and illegal in the psychedelic space? (22:16) - Does FDA approval make it legal or does there need to be a law passed? (22:54) - What needs to happen for the FDA to change their minds on psychedelics after all these years? (24:16) - Would these drugs displace other opiate treatments? (25:25) - The Hype Around Psychedelics in Society (26:42) - What parts of the industry interest you the most? (28:52) - Thoughts on Micro-Dosing (30:14) - Advancements in ways to “stop” the trip (31:31) - Brom’s Personal Experiences with Psychedelics Compass Pathway studies (33:48) - Integration Therapy (34:59) - Do you do any pre-planning or set intentions for psychedelic experiences? (37:29) - Empath’s intentionalities: Receptor Targets, Indications, and Time to Market (41:04) - What does an early-stage psychedelic company look like? (42:26) - What becomes the IP in these companies? (44:07) - Compass Pathways  Freedom Bioscience Partners (45:43) - The Different Experiences from Different Psychedelics (47:25) - Data on effects of psychedelics on minors (49:12) - At what point is testing introduced on humans for new psychedelic molecules? (51:07) - What’s going to happen in this space over the next decade? Wavepaths music (56:30) - Is there any merit in psychedelics as a preventative? (1:00:07) - What’s happened to the brain of people who become depressed? (1:02:01) - What do you predict to be the first mainstream psychedelics? (1:03:25) - How is Oregon doing since decriminalizing drugs? (1:04:01) - How can people track the progress of clinical trials and legislation? (1:04:43) - Wrap Up & Contact Brom on Twitter Empath Ventures The Integration Conversation podcast The Fort is produced by Johnny Podcasts